Beacontx
Founded 2023 · 96 employees on LinkedIn · 1 known investors
Beacon Therapeutics is a clinical-stage biotechnology company developing gene therapies for rare and prevalent ocular diseases, including X-linked retinitis pigmentosa. The company focuses on translating scientific innovation into treatments for inherited retinal diseases.
Founders & leadership
DC
Daniel ChungChief Medical Officer
Investors · 1
Frequently asked questions
- What does Beacontx do?
- Beacon Therapeutics is a clinical-stage biotechnology company developing gene therapies for rare and prevalent ocular diseases, including X-linked retinitis pigmentosa. The company focuses on translating scientific innovation into treatments for inherited retinal diseases.
- Who are Beacontx's investors?
- Beacontx's investors include TCG Crossover.